The Clinical Utilisation and Duration of Treatment with HER2-Directed Therapies in HER2-Positive Recurrent or Metastatic Salivary Gland Cancers

  1. Haigh, J.E.
  2. Patel, K.
  3. Rack, S.
  4. Jiménez-Labaig, P.
  5. Betts, G.
  6. Harrington, K.J.
  7. Metcalf, R.
Zeitschrift:
Current Oncology

ISSN: 1718-7729

Datum der Publikation: 2024

Ausgabe: 31

Nummer: 9

Seiten: 5652-5661

Art: Artikel

DOI: 10.3390/CURRONCOL31090419 GOOGLE SCHOLAR lock_openOpen Access editor
Datenquelle: Scopus